MedTrace Logo

FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)

NCT03170063 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2018-08-20

No results posted yet for this study

Summary

The overall objective of this study is to compare the performance of available oligomeric and phosphorylated a-synuclein assay in cerebrospinal fluid and blood.

Conditions

  • Parkinson Disease

Interventions

PROCEDURE

Procedure/Surgery: Biofluid samplings

Biofluid samplings (blood and cerebrospinal fluid (CSF))

Sponsors & Collaborators

  • University Health Network, Toronto

    collaborator OTHER

  • Indiana University

    collaborator OTHER

  • ICON Clinical Research Limited

    collaborator UNKNOWN

  • Michael J. Fox Foundation for Parkinson's Research

    lead OTHER

Principal Investigators

  • Connie Marras, MD · University Health Network, Toronto

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-08
Primary Completion
2018-03-12
Completion
2018-03-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03170063 on ClinicalTrials.gov